A detailed history of Front Row Advisors LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 6,490 shares of TMO stock, worth $3.51 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
6,490
Previous 6,422 1.06%
Holding current value
$3.51 Million
Previous $3.41 Million 10.68%
% of portfolio
1.43%
Previous 1.6%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $35,959 - $40,761
68 Added 1.06%
6,490 $3.77 Million
Q4 2023

Feb 15, 2024

SELL
$431.41 - $532.94 $10,353 - $12,790
-24 Reduced 0.37%
6,422 $3.41 Million
Q3 2023

Nov 15, 2023

BUY
$498.29 - $574.41 $49,330 - $56,866
99 Added 1.56%
6,446 $3.26 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $71,184 - $82,758
-140 Reduced 2.16%
6,347 $3.31 Million
Q1 2023

May 22, 2023

BUY
$535.0 - $604.82 $1.47 Million - $1.66 Million
2,746 Added 73.4%
6,487 $3.74 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $1.5 Million - $1.69 Million
-2,801 Reduced 42.82%
3,741 $649,000
Q4 2022

Feb 15, 2023

SELL
$484.71 - $571.37 $117,784 - $138,842
-243 Reduced 3.58%
6,542 $3.61 Million
Q3 2022

Nov 15, 2022

SELL
$507.19 - $604.49 $26,881 - $32,037
-53 Reduced 0.78%
6,785 $3.44 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $12,522 - $15,305
-25 Reduced 0.36%
6,838 $3.72 Million
Q1 2022

May 11, 2022

BUY
$524.0 - $644.92 $201,740 - $248,294
385 Added 5.94%
6,863 $4.05 Million
Q4 2021

Mar 09, 2022

BUY
$569.0 - $667.24 $97,868 - $114,765
172 Added 2.73%
6,478 $4.32 Million
Q3 2021

Nov 03, 2021

BUY
$509.53 - $609.78 $22,419 - $26,830
44 Added 0.7%
6,306 $3.61 Million
Q2 2021

Aug 23, 2021

SELL
$441.0 - $508.24 $216,972 - $250,054
-492 Reduced 7.28%
6,262 $3.46 Million
Q1 2021

Apr 28, 2021

BUY
$439.85 - $518.83 $19,793 - $23,347
45 Added 0.67%
6,754 $3.08 Million
Q4 2020

Feb 25, 2021

SELL
$435.06 - $527.66 $19,577 - $23,744
-45 Reduced 0.67%
6,709 $3.13 Million
Q3 2020

Nov 30, 2020

BUY
$359.77 - $441.52 $13,311 - $16,336
37 Added 0.55%
6,754 $3.06 Million
Q2 2020

Aug 17, 2020

SELL
$275.2 - $362.34 $17,062 - $22,465
-62 Reduced 0.91%
6,717 $2.44 Million
Q1 2020

May 08, 2020

SELL
$255.3 - $340.05 $8,935 - $11,901
-35 Reduced 0.51%
6,779 $2.27 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $44,868 - $54,126
-165 Reduced 2.36%
6,814 $2.22 Million
Q3 2019

Nov 08, 2019

SELL
$268.46 - $305.43 $11,543 - $13,133
-43 Reduced 0.61%
6,979 $2.03 Million
Q2 2019

Aug 27, 2019

BUY
$257.51 - $295.55 $154,248 - $177,034
599 Added 9.33%
7,022 $2.06 Million
Q1 2019

May 17, 2019

BUY
$212.17 - $273.72 $22,065 - $28,466
104 Added 1.65%
6,423 $1.76 Million
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $2,084 - $2,519
10 Added 0.16%
6,319 $1.42 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $14,389 - $17,102
70 Added 1.12%
6,309 $1.39 Million
Q2 2018

Jul 31, 2018

BUY
$203.14 - $219.53 $38,596 - $41,710
190 Added 3.14%
6,239 $1.43 Million
Q1 2018

May 21, 2018

BUY
$192.98 - $224.11 $45,157 - $52,441
234 Added 4.02%
6,049 $1.25 Million
Q4 2017

Feb 01, 2018

BUY
$182.03 - $200.37 $1.06 Million - $1.17 Million
5,815
5,815 $1.1 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $212B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.